1 Product identity
Ingredient risk
Contains restricted ingredients
Women's Natural Transition
BrandBanyan Botanicals→Botanical Tablet or Pill 14 ingredients 1 banned DSLD #176278Net contents: 90 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2018-04-25
2 Ingredients (14)
IngredientGroupSafety
Proprietary BlendProprietary Blend (Combination)—
Vidari KandaFinger Leaf Morning Glory—
VetiverVetiver—
ShankhapushpiShankhpushpi—
ArjunaTerminalia—
GuduchiTinospora Cordifolia—
AmalakiIndian Gooseberry—
HaritakiTropical Almond—
MaltodextrinMaltodextrin—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
Ashwagandha 🇩🇰 🇧🇪 🇪🇺 — Banned April 2023 following DTU risk assessment. All products withdrawn.
3 Safety cross-reference
Shatavari — Limited Evidence
⚠ Estrogenic activity
⚠ May worsen kidney disorders (oxalate)
Ashwagandha — Banned in ≥1 country
⚠ Thyroid stimulation
⚠ HEPATOTOXICITY (rare but serious case reports)
Gotu Kola — Conditionally Safe
⚠ Hepatotoxicity (rare)
⚠ Drowsiness
Guggul — Limited Evidence
⚠ GI upset, headache
⚠ Thyroid stimulation
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID176278
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2018-04-25
6 More from Banyan Botanicals
View Banyan Botanicals Safety Scorecard → 33 products
Amalaki TabletsGugguluOrganic ArjunaOrganic AshwagandhaOrganic BacopaOrganic Bhringaraj7 Cite this page
Vancouver
Pkhakadze G. Women's Natural Transition — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 25]. Available from: https://supplement.ge/products/womens-natural-transition-176278/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG